Sort
10,766 grants matching “checkpoint inhibitor”
Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma
$1Sandi Alexander Kwee · Queen'S Medical Center · R01 · FY2025 · CA
53BP1-dependent pathway in DNA repair
$1Junjie Chen · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Targeting of Doppel-axis to Control Lung Tumor Angiogenesis and Immunity
$1Taslim A Al-Hilal · University Of Texas El Paso · R01 · FY2023 · CA
LILRB modulates tumor microenvironment and promotes tumor progression
$1Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2019 · CA
Defining Optimal Radiotherapy Dose and Fractionation in Combination with Preoperative Immuno-Chemotherapy in Early-Stage Triple Negative Breast Cancer
$1Alice Ho · Duke University · R01 · FY2023 · CA
Regulation of the innate immune response in the tumor microenvironment of lung adenocarcinoma
$1Glenn Edward Simmons · University Of Minnesota · K01 · FY2021 · CA
Targeting Posttranslational Modifications in Breast Carcinogenesis
$1Yong Wan · Emory University · R01 · FY2023 · CA
Human Immune Monitoring Shared Resource
$1Richard D Schulick · University Of Colorado Denver · P30 · FY2023 · CA
Targeting posttranslational modifications of B7-H4 in carcinogenesis and therapy
$1Yong Wan · Emory University · R01 · FY2023 · CA
Metabolic reprogramming to improve EGFRvIII CAR T cell persistence
$1John H Sampson · Duke University · R21 · FY2022 · CA
Mechanisms of radioresistance and strategies for radiosensitization in OCCC
$1Guang Peng · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$1Anant Madabhushi · Emory University · R01 · FY2023 · CA
ATR Dependency as a Novel Therapeutic Target in Lethal RB Deficient ProstateCancer
$1Leigh Ellis · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
$1Steven W. Dow · Colorado State University · U01 · FY2021 · CA
[18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors
$1Shivaani Kummar · Oregon Health & Science University · R01 · FY2024 · CA
Image Guided Focused Ultrasound For Drug Delivery and Tissue Ablation
$0Bradford Wood · Clinical Center · ZIA · FY2022 · CL
Investigation of the Effects of a PD1 Inhibitor in a Murine Model of Pneumonia
$0Parizad Torabi-Parizi · Clinical Center · ZIA · FY2021 · CL
Investigation of the Effects of a PD1 Inhibitor in a Murine Model of Pneumonia
$0Parizad Torabi-Parizi · Clinical Center · ZIA · FY2019 · CL
Interventional Oncology
$0Bradford Wood · Clinical Center · ZIA · FY2020 · CL
Image Guided Focused Ultrasound For Drug Delivery and Tissue Ablation
$0Bradford Wood · Clinical Center · ZIA · FY2019 · CL
Modulation of Host Immunity with Dietary Supplements Nicotinamide
$0Parizad Torabi-Parizi · Clinical Center · ZIA · FY2021 · CL
The Effects of Prior Checkpoint Inhibitor (CPI) Therapy on Mouse Hepatitis Coronavirus Induced Pneumonia
$0Parizad Torabi-Parizi · Clinical Center · ZIA · FY2020 · CL
Navigation tools for Image Guided Minimally invasive Therapies
$0Bradford Wood · Clinical Center · ZIA · FY2019 · CL
Investigation of the Effects of a PD1 Inhibitor in a Murine Model of Pneumonia
$0Parizad Torabi-Parizi · Clinical Center · ZIA · FY2020 · CL
Image Guided Focused Ultrasound For Drug Delivery and Tissue Ablation
$0Bradford Wood · Clinical Center · ZIA · FY2018 · CL